[1]CurrentPatentAssignee:MEDCHEMEXPRESSCHINA;HAOYUANCHEMEXPRESS-CN105111191,2018,BLocationinpatent:Paragraph0139;0140;0141
Title: Yin T, et al. A novel CDK9 inhibitor shows potent antitumor efficacy in preclinical hematologic tumor models. Mol Cancer Ther. 2014 Jun;13(6):1442-56. Mol Cancer Ther. 2014 Jun;13(6):1442-56.